UBE3A and familial pancreatic carcinoma: UBE3A interacts with mH2A1 through its N-terminal domain, leading to K48-linked polyubiquitination at the K167 residue, which accelerates mH2A1 degradation and upregulates TERT, enhancing the anti-senescence capacity of pancreatic cancer cells.